Cargando…
Multi-layered genetic approaches to identify approved drug targets
Drugs targeting genes linked to disease via evidence from human genetics have increased odds of approval. Approaches to prioritize such genes include genome-wide association studies (GWASs), rare variant burden tests in exome sequencing studies (Exome), or integration of a GWAS with expression/prote...
Autores principales: | Sadler, Marie C., Auwerx, Chiara, Deelen, Patrick, Kutalik, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363916/ https://www.ncbi.nlm.nih.gov/pubmed/37492104 http://dx.doi.org/10.1016/j.xgen.2023.100341 |
Ejemplares similares
-
From pharmacogenetics to pharmaco-omics: Milestones and future directions
por: Auwerx, Chiara, et al.
Publicado: (2022) -
Quantifying the role of transcript levels in mediating DNA methylation effects on complex traits and diseases
por: Sadler, Marie C., et al.
Publicado: (2022) -
Exploiting the mediating role of the metabolome to unravel transcript-to-phenotype associations
por: Auwerx, Chiara, et al.
Publicado: (2023) -
The individual and global impact of copy-number variants on complex human traits
por: Auwerx, Chiara, et al.
Publicado: (2022) -
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
por: King, Emily A., et al.
Publicado: (2019)